Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

IAVI starts Phase l trial of eOD-GT8 60mer for HIV

Computer image of EOD-GT8 immune-stimulating protein. Credit: Joseph Jardine, Sergey Mennis, and William Schief of TSRI/IAVI.

Go Top